Oncology and Hematology
Episodes 113-125 of 125
Alison J. Moskowitz, MD
Alex Herrera, MD
John P. Leonard, MD
Matthew J. Matasar, MD
Alex Herrera, MD
Kami Maddocks, MD
Alison J. Moskowitz, MD
Sarah Rutherford, MD
Sarah Rutherford, MD
John P. Leonard, MD
John P. Leonard, MD
Sarah Rutherford, MD
Kami Maddocks, MD
Matthew J. Matasar, MD
Alex Herrera, MD
Alison J. Moskowitz, MD
Alex Herrera, MD
Alison J. Moskowitz, MD
Paul P. Doghramji, MD, FAAFP
Rami Komrokji, MD
Allan Platt, PA-C, MMSc
- CME/CE Broadcast Replay
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
1.00 creditNeeraj Agarwal, MD, FASCO
Jason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
Jason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
Jason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
- MinuteCE®
Metastatic Melanoma: Solving Clinical Dilemmas in Frontline ICI Treatment
0.50 credits 3 episodesJason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
- Previous
- Next